NDC 0067-8143

Perdiem

Sennosides, Stimulant Laxative

Perdiem is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The primary component is Sennosides.

• Product ID: 0067-8143_0279e79c-0820-4702-9533-fcce3a23e1ad
• NDC: 0067-8143
• Product Type: Human Otc Drug
• Proprietary Name: Perdiem
• Generic Name: Sennosides, Stimulant Laxative
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2017-07-01
• Marketing Category: OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
• Application Number: part334
• Labeler Name: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
• Substance Name: SENNOSIDES
• Active Ingredient Strength: 15 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 0067-8143-01

1 BOTTLE in 1 CARTON (0067-8143-01) > 60 TABLET in 1 BOTTLE

• Marketing Start Date: 2017-07-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0067-8143-01 [00067814301]

Perdiem TABLET

• Marketing Category: OTC monograph not final
• Application Number: part334
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2017-07-01

Drug Details

Active Ingredients

Ingredient	Strength
SENNOSIDES	15 mg/1

OpenFDA Data

• SPL SET ID: 6b256c8f-3953-4c69-9a16-ffa0511bdbcd
• Manufacturer:
  • GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
• UNII:
  • 3FYP5M0IJX
• RxNorm Concept Unique ID - RxCUI:
  • 200162
  • 404318